न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 100mg - modified release tablet - 100 mg - active: morphine sulfate pentahydrate 100mg excipient: hyetellose hypromellose magnesium stearate opadry grey oy-8238 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 10mg - modified release tablet - 10 mg - active: morphine sulfate pentahydrate 10mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry buff oy-3607 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 30mg - modified release tablet - 30 mg - active: morphine sulfate pentahydrate 30mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry violet 0y-6708 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - morphine sulfate pentahydrate 60mg - modified release tablet - 60 mg - active: morphine sulfate pentahydrate 60mg excipient: hyetellose hypromellose lactose monohydrate magnesium stearate opadry orange oy-3533 povidone purified talc - arrow-morphine la tablets are indicated for the prolonged relief of opioid responsive severe and intractable pain in adults. use in non-malignant pain: the use of arrow-morphine la tablets for the treatment of pain which is not due to malignancy should be restricted to situations where: · all other conservative methods of analgesia have been tried and have failed; · the pain is having a significant impact on the patient's quality of life; · there is no psychological contraindication, drug seeking behaviour or history of drug abuse.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - amitriptyline hydrochloride 25mg;  ;  ;   - film coated tablet - 25 mg - active: amitriptyline hydrochloride 25mg       excipient: colloidal silicon dioxide crospovidone hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose purified talc   quinoline yellow titanium dioxide - for the treatment of depression.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline;   - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg equivalent to 100 mg sertraline   excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline;   - film coated tablet - 50 mg - active: sertraline hydrochloride 55.95mg equivalent to 50 mg sertraline   excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 sodium starch glycolate titanium dioxide - sertraline actavis is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - disodium etidronate 200mg - tablet - 200 mg - active: disodium etidronate 200mg excipient: magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified water

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - brimonidine tartrate 0.2%{relative};   - eye drops, solution - 0.2% w/v - active: brimonidine tartrate 0.2%{relative}   excipient: benzalkonium chloride citric acid polyvinyl alcohol sodium chloride sodium citrate sodium hydroxide water for injection - effective for lowering intraocular pressure in patients with ocular hypertension.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml - eye drops, solution - 0.25% w/v - active: timolol maleate 3.4 mg/ml equivalent to timolol 2.5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection